AMGEN INC (AMGN)
Clinical trial NCT06376045 updates: 1. completion date: 2026-12-11 → 2026-06-22 2. primary completion date: 2026-10-19 → 2026-05-14
Clinical trial NCT06376045 updates: 1. completion date: 2026-12-11 → 2026-06-22 2. primary completion date: 2026-10-19 → 2026-05-14
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical